Meningitis vaccine study for healthy infants and toddlers
Part of Infections clinical trials.
This study tests an experimental meningitis vaccine in healthy babies and toddlers to see how well it works and if it's safe. If your child is between 2 and 23 months old and in good health, they might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 23 months old at the start of the study
- Your child was born full-term (at least 37 weeks) or born between 27 and 36 weeks but is medically stable
- You (the parent or legal guardian) have signed a consent form
- Your child does not have a serious illness, weak immune system, or history of certain health problems like seizures or Guillain-Barré syndrome
- Your child has not had a meningitis vaccine before (for babies 2 to 11 months old) or has not had one in the last 6 months (for toddlers 12 to 23 months old)
- Your child has no bleeding disorder or recent antibiotic use that could interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches for any side effects or health changes after you receive the MenQuadfi vaccine, which protects against four types of meningococcal bacteria. Your doctor will follow up with you to make sure the vaccine is safe and working well.
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This trial tests a new vaccine that helps protect against 6 types of meningococcal bacteria, which can cause serious infections like meningitis. It is for healthy people aged 2 to 59 years.
Hear when a new Meningococcal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.